Shandong Yinfeng
And the Future of Cryonics
The Torch Passes East
In the pale light of a Jinan morning, where the Yellow River’s ancient murmurs mingle with the hum of modern ambition, the Shandong Yinfeng Life Science Research Institute stands as a monument to human hope.
Here, in a sleek facility that could be mistaken for a laboratory of advanced biotech, the air is thick with the chill of liquid nitrogen and the weight of an improbable dream: the defiance of death itself.
Yinfeng, Communist China’s sole cryonics enterprise was founded in 2015 as one division among many employing the staff of a thousand of the Yinfeng Biological Group. But though it’s only a small part of the sprawling enterprises led by Yinfeng, its objective is vast: it aims at more than merely the preservation of irrecoverably lifeless bodies; it cradles the fragile possibility of resurrection. Amid stainless steel tanks chilled to -196°C, it dreams of a future where the dead may stir again, their synaptic awareness restored by sciences yet unborn.
What renders it unique is that Yinfeng’s efforts are supported by government sanction and approval, and buoyed by a nation’s burgeoning faith in technological transcendence.
Figures like Aaron Drake, once a steward of Alcor’s cryostasis vaults in Arizona, and patients like Zhan Wenlian, a lung cancer victim preserved in 2017, are among the many characters who fill this tale of audacity, uncertainty, and the optimism of those who wager on tomorrow.
Machineries of Hope
To step into Yinfeng’s cryonics facility is to cross a threshold between the tangible and the fantastical, where the clinical precision of science meets the poetic yearning for eternity. The Group as a whole, nestled in Shandong’s capital with its staff of a thousand, is a hive of activity. Among them, a few select PhDs and surgeons and others now labor over cryopreservation protocols, organ storage, and the delicate alchemy of cryoprotective agents.
Here, 26 bodies—whole, not merely heads—rest in liquid nitrogen, their cellular clocks halted since the first cryopreservation, that of Zhan Wenlian, in 2017.
In that first case, Gui Junmin, the husband of the woman of 49, entrusted her to Yinfeng’s care. It marked a milestone in China’s emerging encounter with cryonics.
With extracorporeal membrane oxygenation (ECMO) machines sustaining blood flow post-mortem and perfusion techniques borrowed from organ transplants, Yinfeng’s process is a ballet of urgency and exactitude.
The body, cooled to a glassy state, becomes a vessel of potential, its fate tethered to the distant promise of “nanowarming” or neural reconstruction. This enterprise is not a solitary endeavor but a tapestry woven with institutional threads.
Yinfeng’s license from the Shandong Red Cross grants all its operations a legitimacy rare in the cryonics world. Partnerships with Shandong University’s Qilu Hospital and the University of Science and Technology of China lend academic heft, while the Chinese government’s tacit approval—through the Yinfeng Biological Group’s broader biotech ventures—provides a financial and regulatory scaffold quite unlike Western counterparts like Alcor or TomorrowBio, which grapple with public skepticism and legal quagmires.
Cryonics and the Culture, Cryonics and the State
Yinfeng operates in a cultural milieu far less encumbered by parochial caveats from independent judges, or evangelical religious objections. In China, where burial traditions coexist with a hunger for technological progress, cryonics is less a heresy than a bold hypothesis.
Yet, as Aaron Drake, Yinfeng’s former research director, once observed, the act of freezing is merely the opening note; the symphony of revival remains unwritten, its score a matter of faith as much as science.
Unlike the cryonic outposts of the West, which often labor under the weight of public disdain or legal scrutiny, Yinfeng basks in a rare glow of governmental favor. The Shandong Red Cross, an arm of China’s vast bureaucratic tapestry, has granted Yinfeng a license to preserve bodies as “donations to technological research,” a designation that cloaks the speculative in the respectable. This is no small thing in a nation where regulation can choke innovation as swiftly as it nurtures it.
The Yinfeng Biological Group, with its thousand-strong workforce and ventures in stem cells, DNA testing, and aesthetic medicine, is a favored child of Shandong’s economic ambitions, its cryonics arm a curious jewel in a crown of biotech enterprise.
The state’s blessing—less a formal directive than a permissive nod—has allowed Yinfeng to flourish where others falter, its liquid nitrogen tanks a testament to a peculiarly Chinese synthesis of pragmatism and futurism. This governmental embrace sets Yinfeng apart, yet it casts a shadow as much as it illuminates. The institute’s partnerships with institutions like the Shandong Provincial Health Commission and the University of Science and Technology of China weave it into the fabric of national progress, but they also bind it to a system where autonomy is a delicate negotiation.
The Chinese public, less tethered to the theological anxieties that haunt Western cryonics—concerns of souls lost or bodies profaned—views Yinfeng’s work with a blend of curiosity and cautious hope. Here, the Confucian reverence for ancestral rites meets no clash with the modern hunger for longevity. Even so, Yinfeng navigates this tension with care. Li Qingping, the institute’s public affairs director, has reportedly spoken of cryonics as a bridge to a future where death might be a pause, not an end, words that may find an echo in a progressive Asian society increasingly enamored of technology’s redemptive power.
Nonetheless, state support for cryonics, while groundbreaking, raises questions: what does it mean to preserve a body under the aegis of a Communist government that shapes lives under the guiding hand of ideology? For Yinfeng’s 60 signed-up members, hope is a gamble that science, not sovereignty, will ultimately dictate their fate.
Pressing Forward
Yet, to Zhan Wenlian, the woman felled by lung cancer in 2017 and the first to entrust her body to Yinfeng’s care, the question is moot. Her body is now cradled in a 2,000-liter tank of liquid nitrogen, waiting to be joined by her husband, Gui Junmin, signed up alongside her. His decision less a leap of logic than an act of the heart—a hope to meet again in some distant, as yet unimagined Chinese future.
Their story, tender and defiant, is the pulse of Yinfeng’s mission, a reminder that cryonics is not merely a scientific pursuit but a deeply personal one. The institute’s twenty-six patients, their identities largely veiled by confidentiality, are joined by over sixty living members, each a pilgrim in this strange religion of possibility.
Among them are the voices of Lai Weifu, a director who muses on cryonics’ philosophical weight at academic forums, and Li Qingping, whose public advocacy paints preservation as a bridge across time. Yet it is Aaron Drake, an American who carried Alcor’s expertise across continents to Yinfeng from 2016 to 2023, who may best embody Yinfeng’s ambition to wed resurrection to reverie.
A cryonics veteran, Drake oversaw the meticulous choreography of Zhan’s preservation, his hands guiding the infusion of cryoprotectants and the delicate dance of ECMO machines that sustain a body’s fading warmth. His departure left Yinfeng’s team—twenty-two specialists, including surgeons and perfusionists—to carry the torch, their work a testament to the institute’s growing self-reliance. These figures, from the grieving husband to the foreign expert, form a constellation of belief, each drawn to Yinfeng’s promise of a second chance.
And so, Yinfeng presses forward, its ambition fueled by a restless optimism. The institute’s research into organ preservation—pancreatic cells for diabetes, ovarian tissue for fertility—hints at practical victories that could lend cryonics credibility, a stepping stone to the grander goal. Collaborations with the University of Science and Technology of China and the International Association of Cryogenic Medical Engineering weave threads of hope, suggesting that tomorrow’s science might unravel today’s impossibilities. In China, where over a billion souls drive relentlessly toward progress, Yinfeng’s work is less a fringe experiment than a bold hypothesis.
Very slowly—all too slowly, alas—cryonics is moving from the speculative fringe to concrete social reality. The initial steps are small, but for one of the leading governments of Earth to move from dismissal to support, even in the smallest fashion, is to cross a major historical threshold. China, with its vast ambition and unyielding drive, seems a fitting cradle for this audacious experiment, its cultural openness to progress a fertile ground for Yinfeng’s aspirations.
The road ahead is shadowed—by science unperfected, by development unguessed. Yinfeng does not promise an outcome where the frozen will awaken, their stories resumed in a world remade. But in this delicate act of preservation, Yinfeng offers not only a technology but a vision: a gamble that humanity, ever defiant, may one day outwit the silence of the grave.
Citations:
1. Yinfeng as China’s only cryonics institution, confirmed by South China Morning Post (SCMP), Aug 2022.
2. Founded in 2015 by Yinfeng Biological Group. Verified by official site & SCMP.
3. First preservation: Zhan Wenlian (2017), lung cancer victim, preserved at 49. Confirmed by multiple sources including SCMP.
4. Aaron Drake’s involvement (former Alcor professional). Confirmed. Drake began collaborating with Yinfeng in 2016. Source: SCMP, Alcor mentions, Nature.
5. 26 preserved bodies as of 2022. Verified by SCMP, which states Yinfeng has “26 patients in liquid nitrogen.”
6. Partnerships with Shandong Red Cross, Qilu Hospital, and University of Science and Technology of China. SCMP confirms all three. The Red Cross licensed cryonics under “medical donation” status.
7. Use of ECMO and cryoprotectants. These are standard in high-end cryonics protocols and confirmed in interviews with Yinfeng staff and Drake.
8. 60+ living members signed up. SCMP quotes Yinfeng’s cryonics director reporting “over 60 people” registered for future preservation.
Copyright 2025 by The Cryonics Society
Note: all text and commentary in the Cryonics Society web site may not be reproduced without the written prior consent of the authors.
Email: contact @ cryonicssociety.org
Tel.: 585-473-3321